Search the Newsreel

Allegion (NYSE: ALLE) exec exercises options, then sells 549 shares

Allegion plc (ALLE) officer David S. Ilardi, President-Amer & SVP-Allegion, exercised stock options for 549 Ordinary Shares at $71.835 per share on August 18, 2026. On the same day, he sold all 549 newly acquired shares in an open-market transaction at $161.09 per share. …

Why Hyperliquid Strategies (PURR) Stock Is Up Today

Hyperliquid Strategies (PURR) stock rose 8.9% today, likely due to renewed buying interest in Hyperliquid-linked equities rather than a specific company announcement. The company's high sensitivity to the underlying Hyperliquid ecosystem, driven by its large holding of HYPE tokens, suggests a sentiment-driven rally. Large …

Omega Flex Stock Down 6% as Q2 Earnings Decline Year Over Year

Shares of Omega Flex, Inc. OFLX have declined 5.6% since the company reported its earnings for the quarter ended June 30, 2026, compared with a 0.4% decline in the S&P 500 index over the same period. Over the past month, Omega Flex shares have …

US FDA approves Regeneron's rare bone disorder drug

The U.S. FDA has approved Regeneron's experimental drug, garetosmab (branded as Pasatru), for the rare genetic disorder fibrodysplasia ossificans progressiva (FOP). The drug significantly reduced abnormal bone formation in soft tissues, with trials showing a 90-94% reduction in new bone abnormalities. This approval addresses …

NORWEGIAN CRUISE LINE® UNVEILS NEW WAYS TO UNWIND, DINE AND VACATION ABOARD THE SOON-TO-DEBUT NORWEGIAN AURA

Norwegian Cruise Line has unveiled new wellness and dining experiences for its upcoming ship, Norwegian Aura. The ship will feature the industry's most expansive Thermal Spa with 15 wellness experiences, NCL's first specialty Indian restaurant called Tamara, and The Panorama Room, an immersive complimentary …

Regeneron Pharmaceuticals Announces FDA Approval of Pasatru for Adults With Fibrodysplasia Ossificans Progressiva

Regeneron Pharmaceuticals has received FDA approval for Pasatru™ (garetosmab-grts) to treat adults with fibrodysplasia ossificans progressiva (FOP), a rare genetic disorder characterized by debilitating bone growth. The approval is based on Phase 3 OPTIMA trial results showing a 90-94% reduction in new heterotopic ossification …

Regeneron wins FDA nod for rare bone disorder therapy

[FDA Headquarters] * The U.S. Food and Drug Administration on Wednesday approved Pasatru, a treatment developed by Regeneron (REGN [https://seekingalpha.com/symbol/REGN]) for adults with an ultra-rare bone growth disorder known as fibrodysplasia ossificans progressiva. * Earlier this year, the regulator granted priority review for the …

Regeneron rare bone disorder therapy approved (REGN:NASDAQ)

The U.S. Food and Drug Administration (FDA) has approved Regeneron's drug, Pasatru, for treating fibrodysplasia ossificans progressiva (FOP), an ultra-rare bone growth disorder in adults. This approval follows the regulator's earlier decision to grant priority review for the company's Biologics License Application. This development …

Region Group (ASX:RGN) Shares Struggle To Trust Solid FFO Growth

Die Eckert-&-Ziegler-Aktie pendelt um 13,30 Euro nach jüngsten Zahlen

ATI Slides 3.9% as Investors May Be Locking In Gains After Recent Rally

ATI Inc. (ATI) stock declined by 3.9% today, likely due to profit-taking by investors after a recent rally. The company had reported strong Q2 2026 results and raised its full-year outlook, with no new negative company-specific news identified. Insider trading shows 22 sales and …

Pegasystems (PEGA) Stock Trades Up, Here Is Why

Shares of Pegasystems (PEGA) rose 3.7% after the company announced a partnership with Gryphon and introduced new AI tools for marketing compliance and transparency. This comes after a significant drop in its stock price due to a slowdown in contract growth and weaker forward-looking …

Leggett & Platt Inc. stock outperforms competitors on strong trading day

Leggett & Platt Inc. (LEG) shares increased by 3.42% to $9.68 on Wednesday, outperforming the broader market which also saw gains in the S&P 500 and Dow Jones Industrial Average. This rise ended a three-day losing streak for the company's stock.

IRBR3 - Irb - Resultados, Dividendos, Cotação e Indicadores

Norwegian Cruise Line Holdings Ltd. stock underperforms Wednesday when compared to competitors

Norwegian Cruise Line Holdings Ltd. (NCLH) stock fell by 1.53% on Wednesday, closing at $17.34. This underperformance occurred despite a positive trading session for the broader market, with both the S&P 500 Index and the Dow Jones Industrial Average seeing gains. The stock experienced …

Donegal Mutual Insurance acquires $371,194 of Donegal Group common shares

Donegal Mutual Insurance, a 10% owner of Donegal Group, purchased 20,000 Class A common shares for approximately $371,194 through open-market transactions. This acquisition increased their Class A stake to 14.17 million shares, while their Class B holdings remained at 4.75 million shares. The transaction …

REGN Investor Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Notice - Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed a class action lawsuit against Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on behalf of investors who purchased securities between August 1, 2025, and May 15, 2026. The lawsuit alleges that Regeneron gave an overly positive view of its Phase …

Entegris (ENTG) CEO uses stock to cover tax bill on RSUs

Entegris (ENTG) President & CEO David Reeder had 5,386 shares of common stock withheld at $150.27 per share to cover tax obligations arising from the settlement of restricted stock units on August 18, 2026. This transaction, categorized as a Code F disposition, is not …

EG Maintained by Everest Group -- Price Target Raised to $385

TD Cowen analyst Andrew Kligerman maintained a 'Hold' rating for Everest Group Ltd (EG) and raised its price target from $365.00 to $385.00. The stock is considered approximately 0.4% overvalued according to GuruFocus's GF Value, despite having a strong GF Score of 75/100, indicating …

NCLH's 8.9% Q3 Net Yield Drop Raises the Stakes for Its 2027 Reset

Norwegian Cruise Line Holdings Ltd. (NCLH) faces a significant challenge with an expected 8.9% drop in constant-currency net yield for Q3, and a 5% decline projected for 2026. This puts immense pressure on the company's commercial reset strategy, which aims to rebuild demand and …

Regional (RM) Results Review: Profit Per Share Clears Its Benchmark in the Latest Session; Stock Move: Shares Move Higher 0.42% in the Current Update - Revenue Guidance Update

Is NCLH Cheap Enough to Buy Despite Its Earnings and Leverage Risks?

Norwegian Cruise Line Holdings Ltd. NCLH trades at a steep sales-multiple discount, but the lower valuation arrives as earnings estimates fall and leverage stays high. The key question is whether that discount already compensates investors for the depth and duration of the 2026 commercial …

Q2 2026 Entegris Inc Earnings Call Transcript

This article provides the transcript of Entegris Inc.'s Q2 2026 earnings call, detailing key financial highlights and strategic developments. The company exceeded guidance with 11% revenue growth, strong free cash flow, and debt reduction. It also covers strategic shifts, such as exiting the life …

Hyperliquid Strategies (PURR) Climbs As Crypto Rules Evolve

Hyperliquid Strategies Inc (PURR) stock has climbed by 12.85% following news related to SEC crypto rulemaking, even though the company is only mentioned in metadata rather than being the central focus. Despite the lack of direct company-specific news, PURR's chart shows a strong, controlled …

Hyperliquid Strategies PURR Gains Momentum As Crypto Rules Loom

Hyperliquid Strategies Inc. (NASDAQ: PURR) is experiencing a significant surge, with its stock trading up by 12.85% due to investor optimism surrounding its breakthrough AI trading platform. Despite a high price-to-sales ratio, the company exhibits strong financial health, including substantial revenue, net income, and …

Q2 Rundown: Power Integrations (NASDAQ:POWI) Vs Other Analog Semiconductors Stocks

The article provides a Q2 earnings rundown for Power Integrations (NASDAQ:POWI) and compares its performance to other analog semiconductor stocks. It highlights strong Q2 results across the analog semiconductor industry, with Power Integrations exceeding revenue and EPS expectations but seeing a stock dip. The …

Pegasystems (PEGA) grants director 7,947 fully vested options at $32.32

Pegasystems (PEGA) director Sharon T. Rowlands was granted 3,868 shares of unrestricted common stock and 7,947 fully vested non-statutory stock options with an exercise price of $32.32 per share, expiring in 2036. These awards were compensation for her annual director service. Following these transactions, …

MSTR Stock Quote Price and Forecast

Sol Strategies Inc. Revenue Breakdown – CSE:HODL

Sol Strategies Inc. (CSE: HODL) generated 14.56 million CAD in revenue last year, primarily from its Cryptocurrencies and Blockchain Technology segment. This marks an increase from 9.53 million CAD in the previous year. Canada was the sole contributor to this revenue, accounting for the …

Is IART Still Attractive as Its Low Valuation Meets Execution Risks?

Integra LifeSciences Holdings Corp. (IART) trades at a significant valuation discount compared to its industry and market benchmarks, driven by recent margin gains and improved operating execution. However, the company faces challenges including modest revenue growth, elevated leverage, and unresolved regulatory remediation with the …

Greggs Stock And Other UK Consumer Shares Worth Watching As Inflation Rises

Sol (STKE) EPS and Revenue: The EPS Result Is Below Expectation in the Latest Session; Investor Response: The Share Price Adds 0.96% in the Latest Reading - Upward Estimate Revision

Regeneron halts first-in-human REGN7041 trial after safety event

Regeneron has terminated its Phase I/II clinical trial for REGN7041, an anti-CD3 monoclonal antibody for non-infectious uveitis, after only one participant was enrolled due to a safety event. The company voluntarily ended the TITAN study following a risk-benefit reassessment, although the underlying cause of …

Regal Partners Says Subsidiary Bankruptcy Unlikely to Hit Group Operations

Are Aerospace Stocks Lagging ATI INC (ATI) This Year?

This article analyzes whether ATI Inc. (ATI) is outperforming its peers in the Aerospace sector. It highlights that ATI has gained 97.3% year-to-date, significantly outperforming the Aerospace sector's average gain of 7.5%. The article also notes ATI's Zacks Rank of #1 (Strong Buy) and …

Donegal Mutual Insurance buys $371,194 of Donegal Group stock

Donegal Mutual Insurance Co., a significant owner of Donegal Group Inc. (NASDAQ:DGICA), recently purchased 20,000 shares for $371,194, indicating a belief the stock is undervalued according to InvestingPro. These transactions, occurring on August 17 and 18, 2026, increased Donegal Mutual's holdings, while Donegal Group …